Ask AI
DATO Base Cohort C
DATO-Base Cohort C: Datopotamab Deruxtecan in HER2-Negative Metastatic Breast Cancer With Leptomeningeal Disease

Released: December 17, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 17, 2025